Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Novo Nordisk’s Ozempic and Wegovy Reshape Denmark’s Economy

Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.

Eshe Nelson
Author: Eshe Nelson

Written by

Eshe Nelson

in

Denmark, Diabetes, Drugs (Pharmaceuticals), Economic Conditions and Trends, Gross Domestic Product, Novo Nordisk A/S, Ozempic (Drug), Semaglutide (Drug)
←Oliver Anthony Music’s ‘Rich Men North of Richmond’ Stays No. 1
France To Ban Muslim Students From Wearing Abayas In Schools→

More posts

  • Trump coins already out of stock at US Mint

  • Wednesday’s Mini-Report, 9.2.26

  • Trump calls Tiger Woods plea deal ‘very fair’

  • Infighting at DOJ boils over in latest sign of Trump administration’s chaos

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube